Learn More
Medchemexpress LLC Guadecitabine sodium | 929904-85-8 | C18H23N9NaO10P | 50 MG

Supplier: Medchemexpress LLC HY1522950MG
Guadecitabine sodium is a second-generation DNA methyltransferases (DNMT) inhibitor. It is used for research of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This product is for research use only and not sold to patients.
- Inhibits DNA methylation.
- Increases p16 expression in HCT116 colorectal carcinoma and T24 cells.
- Shows reduced toxicity compared to 5-aza-CdR at lower doses.
- Reduces DNA methylation and retards tumor growth in vivo.
- Exhibits improved tolerability in vivo compared to 5-Aza-CdR.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.